Literature DB >> 3500727

HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.

J E Richardson1, D D Gladman, A Fam, E C Keystone.   

Abstract

Forty-three patients with well-documented giant cell arteritis (GCA) were studied clinically and with HLA typing. All patients were over age 40. Twenty-two of the patients had coexistent polymyalgia rheumatica (PMR). No association with class I HLA antigens was detected. When compared with HLA findings in 243 healthy controls, HLA-DR4 was increased in patients with GCA and PMR, but not in patients with GCA alone. Pooled analysis of data from 4 published papers confirmed the association of DR4 with GCA and PMR (P much less than 0.00001). Patients with PMR but negative findings of temporal artery biopsies also showed an increased frequency of HLA-DR4, but this did not reach statistical significance, probably because of the small number of subjects. It is likely that the increased frequency of DR4 in GCA patients is related to its association with PMR.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500727     DOI: 10.1002/art.1780301113

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity.

Authors:  C Salvarani; L Boiardi; V Mantovani; A Ranzi; F Cantini; I Olivieri; M Bragliani; E Collina; P Macchioni
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

2.  Epidemiology of giant cell arteritis in an Arab population: a 22-year study.

Authors:  Neil R Miller
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

3.  A seasonal pattern in the onset of polymyalgia rheumatica.

Authors:  M A Cimmino; R Caporali; C M Montecucco; S Rovida; E Baratelli; M Broggini
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

Review 4.  Giant cell arteritis with ocular complications discovered simultaneously in two sisters.

Authors:  F Gros; J F Maillefert; A Behin; F Guignier; C Piroth; C Creuzot-Garcher; C Tavernier
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we?

Authors:  Chikashi Terao
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 6.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

7.  The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.

Authors:  C M Weyand; K C Hicok; G G Hunder; J J Goronzy
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 8.  Epidemiology and optimal management of polymyalgia rheumatica.

Authors:  P Labbe; P Hardouin
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

9.  Fatal aortic dissection in a patient with giant cell arteritis: a case report and review of the literature.

Authors:  Anjeli K Nayar; Michael Casciello; Jennifer N Slim; Ahmad M Slim
Journal:  Case Rep Vasc Med       Date:  2013-02-26

10.  Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Authors:  Sarah Louise Mackie; John C Taylor; Lubna Haroon-Rashid; Stephen Martin; Bhaskar Dasgupta; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Colin T Pease; Jennifer H Barrett; Richard Watts; Ann W Morgan
Journal:  Arthritis Res Ther       Date:  2015-07-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.